S. Zancan

发表

Cerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo

T. Furmark, M. Fredrikson, M. Bergström, 2005, Biological Psychiatry.

Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID

A. Aiuti, S. Zancan, Pauline Ng, 2018, Orphanet Journal of Rare Diseases.

Toward Reference Intervals of ARSA Activity in the Cerebrospinal Fluid: Implication for the Clinical Practice of Metachromatic Leukodystrophy.

F. Morena, S. Martino, A. Biffi, 2020, The journal of applied laboratory medicine.

Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy

A. Biffi, A. Aiuti, R. Miniero, 2019, Bone Marrow Transplantation.

Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.

V. Gallo, S. Galimberti, M. Valsecchi, 2021, The New England journal of medicine.

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

V. Gallo, P. Rancoita, C. Di Serio, 2022, The Lancet.

Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: Initial validation of an imaging protocol for drug discovery

Jesús Pujol, Carles Soriano-Mas, Paolo Fina, 2014, European Neuropsychopharmacology.

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe

O. Finco, E. Marchetti, A. Podda, 2017, EBioMedicine.

Lentiviral hematopoietic stem and progenitor cell gene therapy provides durable clinical benefit in early-symptomatic early-juvenile metachromatic leukodystrophy

M. Filippi, V. Gallo, L. Naldini, 2021 .

Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients

M. Filippi, V. Gallo, L. Naldini, 2020 .

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.

C. Cancrini, P. Rancoita, C. Di Serio, 2024, Nature medicine.

Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome

M. Valsecchi, S. Pontesilli, C. Baldoli, 2024, Science Translational Medicine.